RxDoctor Payments Data

Anika Vaughn-Cooke, MD

Psychiatry · Philadelphia, PANPI 1376779470

Payments from drug & device makers

$5,607in general payments, 2019–2025

Across 247 payments — averaging $22.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$932
  • Teva Pharmaceuticals USA, Inc.$773
  • Neurocrine Biosciences, Inc.$696
  • Alkermes, Inc.$685
  • Otsuka America Pharmaceutical, Inc.$571
  • AbbVie$564
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$5,39996%
  • Education$2084%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,607 in reported general payments places this provider in the 90th percentile of 1,838 psychiatry providers in Pennsylvania.

See all psychiatry providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$56,348
Medicare patients
116
Services billed
437

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl13$18,000
Lurasidone Hcl11$9,050
Chlorpromazine Hcl17$7,832
Ziprasidone Hcl71$3,791
Olanzapine112$2,026
Aripiprazole32$1,716
Bupropion XlBupropion Hcl65$1,645
Haloperidol35$1,623
Quetiapine Fumarate94$1,604
Mirtazapine40$990
Fluphenazine Decanoate12$923
Duloxetine Hcl49$794
Quetiapine Fumarate ErQuetiapine Fumarate24$724
Oxcarbazepine27$710
Divalproex Sodium41$651

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$564$18,00013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,838 psychiatry providers in Pennsylvania.

Other psychiatry in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →